Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Immuron Limited ( (AU:IMC) ) is now available.
Immuron Limited has issued 179,664 ordinary shares without disclosure under Part 6D.2 of the Corporations Act, in compliance with relevant provisions. This issuance reflects the company’s ongoing adherence to regulatory requirements, potentially impacting its market operations and stakeholder interests.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry, focusing on the development and commercialization of oral immunotherapeutics for the treatment of gut-mediated diseases.
YTD Price Performance: -40.0%
Average Trading Volume: 31,579
Technical Sentiment Signal: Strong Buy
Current Market Cap: €7.83M
For detailed information about IMC stock, go to TipRanks’ Stock Analysis page.